Evidence map›Paper›PMID 31825824›Full record

ArticleCell reports2019

Distinct Hepatic PKA and CDK Signaling Pathways Control Activity-Independent Pyruvate Kinase Phosphorylation and Hepatic Glucose Production.

Brandon M Gassaway, Rebecca L Cardone, Anil K Padyana, Max C Petersen, Evan T Judd, Sebastian Hayes, Shuilong Tong, Karl W Barber, Maria Apostolidi, Abudukadier Abulizi and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Brandon M GassawayDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Systems Biology Institute, Yale University, New Haven, CT, USA.
Rebecca L CardoneDepartment of Internal Medicine, Yale University, New Haven, CT, USA.
Anil K PadyanaAgios Pharmaceuticals, Cambridge, MA, USA.
Max C PetersenDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Internal Medicine, Yale University, New Haven, CT, USA.
Evan T JuddAgios Pharmaceuticals, Cambridge, MA, USA.
Sebastian HayesAgios Pharmaceuticals, Cambridge, MA, USA.
Shuilong TongViva Biotech, Shanghai, China.
Karl W BarberDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Systems Biology Institute, Yale University, New Haven, CT, USA.
Maria ApostolidiDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Systems Biology Institute, Yale University, New Haven, CT, USA.
Abudukadier AbuliziDepartment of Internal Medicine, Yale University, New Haven, CT, USA.
Joshua B SheetzDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA.
KshitizDepartment of Systems Biology Institute, Yale University, New Haven, CT, USA; Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Hans R AerniDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Systems Biology Institute, Yale University, New Haven, CT, USA.
Stefan GrossAgios Pharmaceuticals, Cambridge, MA, USA.
Charles KungAgios Pharmaceuticals, Cambridge, MA, USA.
Varman T SamuelDepartment of Internal Medicine, Yale University, New Haven, CT, USA; Veterans Affairs Medical Center, West Haven, CT, USA.
Gerald I ShulmanDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Internal Medicine, Yale University, New Haven, CT, USA.
Richard G KibbeyDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Internal Medicine, Yale University, New Haven, CT, USA.
Jesse RinehartDepartment of Cellular and Molecular Physiology, Yale University, New Haven, CT, USA; Department of Systems Biology Institute, Yale University, New Haven, CT, USA. Electronic address: jesse.rinehart@yale.edu.
Yale University · USAgios Pharmaceuticals (United States) · USVeterans Health Administration · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
The Regulation of Renal Epithelial Cell Junction Assembly and PolarizationP01DK017433 · NIDDK · YALE UNIVERSITY · PI CAPLAN, MICHAEL J. · 1986 to 2018
$29.5M
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin ResistanceR01DK113984 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2017 to 2021
$3.7M
Revealing substrates and phosphoproteome level function of human STE20 kinasesR01GM117230 · NIGMS · YALE UNIVERSITY · PI ISAACS, FARREN J., RINEHART, JESSE · 2015 to 2024
$3.2M
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue MetabolismR01DK108283 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G, MASON, GRAEME F. · 2016 to 2019
$2.1M
Chastening the double-edged sword of glucose metabolism in beta-cellsR01DK110181 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G · 2016 to 2019
$1.7M
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1R01DK116774 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2018 to 2021
$1.7M
Novel mechanisms of insulin receptor inhibition in liver by nPKCs and MARCH1F30DK104596 · NIDDK · YALE UNIVERSITY · PI PETERSEN, MAX CHRISTIAN · 2015 to 2017
$124k
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS F30 DK104596NIDDK NIH HHS P01 DK017433NIDDK NIH HHS P30 DK034989NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK108283NIDDK NIH HHS R01 DK110181NIDDK NIH HHS R01 DK113984NIDDK NIH HHS R01 DK116774NIGMS NIH HHS R01 GM117230NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Pyruvate kinase is an important enzyme in glycolysis and a key metabolic control point. We recently observed a pyruvate kinase liver isoform (PKL) phosphorylation site at S113 that correlates with insulin resistance in rats on a 3 day high-fat diet (HFD) and suggests additional control points for PKL activity. However, in contrast to the classical model of PKL regulation, neither authentically phosphorylated PKL at S12 nor S113 alone is sufficient to alter enzyme kinetics or structure. Instead, we show that cyclin-dependent kinases (CDKs) are activated by the HFD and responsible for PKL phosphorylation at position S113 in addition to other targets. These CDKs control PKL nuclear retention, alter cytosolic PKL activity, and ultimately influence glucose production. These results change our view of PKL regulation and highlight a previously unrecognized pathway of hepatic CDK activity and metabolic control points that may be important in insulin resistance and type 2 diabetes.

Indexed as

GluconeogenesisSignal TransductionAnimalsCell Line, TumorCells, CulturedCyclic AMP-Dependent Protein KinasesCyclin-Dependent KinasesDiet, High-FatGlucoseHepatocytesInsulin ResistanceMalePhosphorylationPyruvate KinaseRatsRats, Sprague-DawleyCyclic AMP-Dependent Protein KinasesCyclin-Dependent KinasesGlucosePyruvate Kinasecyclin-dependent kinaseenzyme regulationhepatic glucose productioninsulin resistancemetabolismnuclear localizationphosphorylationpyruvate kinasesub-cellular localization

Identifiers

PMID31825824
PMCPMC6951436
OpenAlexW2992689798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.